Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-20 11:40 am Purchase |
2022-12-02 | 13D | CASI Pharmaceuticals, Inc. CASI |
SPARKLE BYTE LTD | 1,019,852 7.600% |
0 (+0.00%) |
Filing History |
| 2023-02-21 07:33 am Purchase |
2022-06-01 | 13D | CASI Pharmaceuticals, Inc. CASI |
Ho Chi Sing | 1,053,638 7.700% |
68,801 (+6.99%) |
Filing History |
| 2023-02-09 10:48 am Sale |
2023-01-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
FEDERATED HERMES INC. FHI |
661,070 4.860% |
-239,581 (-26.60%) |
Filing History |
| 2023-02-01 10:39 am Purchase |
2022-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
FEDERATED HERMES INC. FHI |
900,651 6.620% |
900,651 (New Position) |
Filing History |
| 2022-06-21 4:26 pm Purchase |
2022-06-13 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,761,349 18.950% |
2,761,349 (New Position) |
Filing History |
| 2022-02-14 1:55 pm Sale |
2021-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
Consonance Capital Management LP | 0 0.000% |
-757,643 (Position Closed) |
Filing History |
| 2022-02-14 1:21 pm Purchase |
2021-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
10,150,000 7.260% |
3,150,000 (+45.00%) |
Filing History |
| 2021-11-23 5:15 pm Purchase |
2021-11-18 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,598,199 17.470% |
438,000 (+20.28%) |
Filing History |
| 2021-04-30 4:11 pm Sale |
2021-04-26 | 13D | CASI Pharmaceuticals, Inc. CASI |
SPECTRUM PHARMACEUTICALS INC SPPI |
688,696 4.900% |
-234,736 (-25.42%) |
Filing History |
| 2021-02-17 3:09 pm Purchase |
2020-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
Consonance Capital Management LP | 757,643 6.110% |
151,793 (+25.05%) |
Filing History |
| 2021-02-16 2:20 pm Purchase |
2020-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
Consonance Capital Management LP | 605,851 9.990% |
605,851 (New Position) |
Filing History |
| 2021-02-12 3:01 pm Purchase |
2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
7,000,000 5.650% |
7,000,000 (New Position) |
Filing History |
| 2021-02-03 4:01 pm Purchase |
2021-02-01 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,160,199 16.260% |
384,747 (+21.67%) |
Filing History |
| 2020-08-18 4:04 pm Purchase |
2020-08-18 | 13D | CASI Pharmaceuticals, Inc. CASI |
SPECTRUM PHARMACEUTICALS INC SPPI |
923,432 7.500% |
923,432 (New Position) |
Filing History |
| 2020-07-29 5:16 pm Purchase |
2020-07-24 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 1,775,452 13.780% |
520,900 (+41.52%) |
Filing History |